LPL Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $123M | Sell |
969,813
-41,751
| -4% | -$5.5M | 0.03% | 563 |
|
|
2026
Q1 | $141M | Sell |
1,011,564
-70,950
| -7% | -$9.94M | 0.04% | 449 |
|
|
2025
Q4 | $133M | Buy |
1,082,514
+45,512
| +4% | +$5.53M | 0.04% | 455 |
|
|
2025
Q3 | $115M | Buy |
1,037,002
+42,885
| +4% | +$4.87M | 0.03% | 472 |
|
|
2025
Q2 | $110M | Sell |
994,117
-87,328
| -8% | -$9.29M | 0.04% | 445 |
|
|
2025
Q1 | $121M | Sell |
1,081,445
-125,027
| -10% | -$12.9M | 0.05% | 369 |
|
|
2024
Q4 | $111M | Buy |
1,206,472
+69,091
| +6% | +$6.22M | 0.05% | 366 |
|
|
2024
Q3 | $95.4M | Buy |
1,137,381
+78,839
| +7% | +$6.02M | 0.04% | 389 |
|
|
2024
Q2 | $72.6M | Buy |
1,058,542
+20,186
| +2% | +$1.35M | 0.04% | 443 |
|
|
2024
Q1 | $76.1M | Buy |
1,038,356
+158,023
| +18% | +$12.2M | 0.04% | 408 |
|
|
2023
Q4 | $71.3M | Buy |
880,333
+24,748
| +3% | +$1.93M | 0.04% | 386 |
|
|
2023
Q3 | $64.1M | Buy |
855,585
+47,547
| +6% | +$3.66M | 0.04% | 376 |
|
|
2023
Q2 | $62.3M | Sell |
808,038
-99,354
| -11% | -$7.92M | 0.04% | 382 |
|
|
2023
Q1 | $75.3M | Sell |
907,392
-265,790
| -23% | -$22M | 0.06% | 300 |
|
|
2022
Q4 | $101M | Buy |
1,173,182
+55,385
| +5% | +$4.39M | 0.09% | 211 |
|
|
2022
Q3 | $69M | Buy |
1,117,797
+114,767
| +11% | +$7.24M | 0.07% | 273 |
|
|
2022
Q2 | $62M | Buy |
1,003,030
+188,351
| +23% | +$11.7M | 0.06% | 299 |
|
|
2022
Q1 | $48.4M | Buy |
814,679
+46,842
| +6% | +$2.99M | 0.04% | 366 |
|
|
2021
Q4 | $55.8M | Buy |
767,837
+54,957
| +8% | +$3.79M | 0.05% | 342 |
|
|
2021
Q3 | $49.8M | Buy |
712,880
+68,556
| +11% | +$4.82M | 0.05% | 347 |
|
|
2021
Q2 | $44.4M | Buy |
644,324
+33,283
| +5% | +$2.22M | 0.04% | 354 |
|
|
2021
Q1 | $39.5M | Buy |
611,041
+8,681
| +1% | +$560K | 0.05% | 348 |
|
|
2020
Q4 | $35.1M | Buy |
602,360
+58,886
| +11% | +$3.55M | 0.05% | 326 |
|
|
2020
Q3 | $34.3M | Buy |
543,474
+97,776
| +22% | +$6.78M | 0.05% | 291 |
|
|
2020
Q2 | $34.3M | Sell |
445,698
-114,582
| -20% | -$8.78M | 0.06% | 268 |
|
|
2020
Q1 | $41.9M | Buy |
560,280
+126,556
| +29% | +$8.74M | 0.09% | 197 |
|
|
2019
Q4 | $28.2M | Buy |
433,724
+3,983
| +0.9% | +$259K | 0.05% | 290 |
|
|
2019
Q3 | $27.2M | Buy |
429,741
+186,870
| +77% | +$12.2M | 0.06% | 272 |
|
|
2019
Q2 | $16.4M | Buy |
242,871
+1,849
| +0.8% | +$122K | 0.04% | 377 |
|
|
2019
Q1 | $15.7M | Sell |
241,022
-14,994
| -6% | -$997K | 0.04% | 362 |
|
|
2018
Q4 | $16M | Sell |
256,016
-23,013
| -8% | -$1.61M | 0.04% | 320 |
|
|
2018
Q3 | $21.5M | Sell |
279,029
-7,374
| -3% | -$557K | 0.05% | 284 |
|
|
2018
Q2 | $20.3M | Sell |
286,403
-32,494
| -10% | -$2.29M | 0.05% | 284 |
|
|
2018
Q1 | $24M | Sell |
318,897
-12,710
| -4% | -$1.01M | 0.07% | 236 |
|
|
2017
Q4 | $23.8M | Buy |
331,607
+34,823
| +12% | +$2.64M | 0.07% | 224 |
|
|
2017
Q3 | $24M | Buy |
296,784
+2,482
| +0.8% | +$190K | 0.08% | 201 |
|
|
2017
Q2 | $20.8M | Buy |
294,302
+223,972
| +318% | +$14.9M | 0.08% | 208 |
|
|
2017
Q1 | $4.72M | Buy |
70,330
+15,764
| +29% | +$1.11M | 0.03% | 444 |
|
|
2016
Q4 | $4.04M | Sell |
54,566
-20,791
| -28% | -$1.55M | 0.03% | 493 |
|
|
2016
Q3 | $5.82M | Sell |
75,357
-20,611
| -21% | -$1.67M | 0.06% | 330 |
|
|
2016
Q2 | $8.22M | Sell |
95,968
-697,154
| -88% | -$61.9M | 0.07% | 232 |
|
|
2016
Q1 | $75.8M | Sell |
793,122
-85,011
| -10% | -$7.67M | 0.21% | 104 |
|
|
2015
Q4 | $87.2M | Buy |
878,133
+383,518
| +78% | +$39.9M | 0.24% | 91 |
|
|
2015
Q3 | $49.1M | Buy |
494,615
+92,638
| +23% | +$10.3M | 0.27% | 79 |
|
|
2015
Q2 | $46.5M | Buy |
401,977
+9,613
| +2% | +$1.05M | 0.24% | 87 |
|
|
2015
Q1 | $38.3M | Buy |
392,364
+36,356
| +10% | +$3.69M | 0.2% | 102 |
|
|
2014
Q4 | $33.6M | Buy |
356,008
+55,593
| +19% | +$5.75M | 0.18% | 113 |
|
|
2014
Q3 | $31.7M | Buy |
300,415
+52,248
| +21% | +$5.12M | 0.19% | 109 |
|
|
2014
Q2 | $20.6M | Buy |
248,167
+1,303
| +0.5% | +$101K | 0.12% | 168 |
|
|
2014
Q1 | $17.5M | Sell |
246,864
-8,898
| -3% | -$698K | 0.11% | 182 |
|
|
2013
Q4 | $19.2M | Buy |
255,762
+15,785
| +7% | +$1.1M | 0.12% | 162 |
|
|
2013
Q3 | $15.3M | Buy |
239,977
+13,020
| +6% | +$778K | 0.1% | 182 |
|
|
2013
Q2 | $11.6M | Buy |
+226,957
| New | +$11.8M | 0.08% | 214 |
|
Other funds holding GILD
LPL Financial's GILD Position: Q2 2026 in Review
LPL Financial reduced its Gilead Sciences (GILD) stake by 4.1% in Q2 2026, selling an estimated $5.5M and leaving 969,813 shares worth $123M. The position accounts for 0.03% of the portfolio, ranked #563.
LPL Financial first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $141M in Q1 2026. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- LPL Financial held 969,813 shares of Gilead Sciences worth $123M as of Q2 2026.
- LPL Financial sold 41,751 Gilead Sciences shares in Q2 2026, an estimated $5.5M.
- Gilead Sciences made up 0.03% of LPL Financial's portfolio in Q2 2026, its #563 holding.
- LPL Financial first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- LPL Financial's Gilead Sciences position peaked at $141M in Q1 2026.
- 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.